Actionable news
All posts from Actionable news
Actionable news in ACRX: AcelRx Pharmaceuticals, Inc.,

AcelRx's (ACRX) CEO Howie Rosen on Q3 2015 Results - Earnings Call Transcript


Good afternoon. And welcome to the AcelRx Third Quarter 2015 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Timothy Morris, Chief Financial Officer. Please go ahead, sir.

Timothy Morris - Chief Financial Officer

Thank you, Gary. Good afternoon, everyone, and welcome to today’s call. On this call I’m joined by Howie Rosen, Interim Chief Executive Officer and Pam Palmer, our Co-Founder and Chief Medical Officer.

During the call today, we will make forward-looking statements, including but not limited to statements related to future financial results, including process and timing of anticipated future development of AcelRx’s product candidates including Zalviso and ARX-04, the timing and quality of data for ARX-04 and the therapeutic a commercial potential of AcelRx Pharmaceuticals product candidate including Zalviso and ARX-04 anticipated results and timing of the completion of the SAP302...